-
Did OXiGENE Win a Crucial Battle In the Fight Against Cancer?
Wednesday, March 12, 2014 - 4:52pm | 224Read More...On Tuesday, OXiGENE (NASDAQ: OXGN) announced that a Phase 2 trial of its ZYBRESTAT ovarian cancer drug has “met its primary endpoint of a statistically significant increase in progress-free survival” of patients with ovarian cancer. Patients given a combination of ZYBRESTAT with an already...
-
Top Trending Tickers On StockTwits For March 12
Wednesday, March 12, 2014 - 10:25am | 715Read More...Here's a look at the top tickers trending on StockTwits.com. Plug Power: So now what? Yesterday's 40.8 percent collapse in Plug Power (NASDAQ: PLUG) shares the Stock Twits community are debating how to proceed from here. Yesterday's 40.8 percent collapse in shares of Plug Power (NASDAQ: PLUG)...
